Finance Advisory Committee

The Mission:

To build relationships between and among financial professionals throughout the BioNJ Membership and the NJ life sciences ecosystem to foster educational and professional community,  information sharing and peer to peer collaboration to facilitate scientific and medical advancement through financial stewardship.

The Vision:

A highly networked ecosystem and platform for CFO professionals to leverage best practices and experience to optimize funding accessibility and opportunities for life science innovation to drive advancements in patient care.

Committee Members

ADMA Biologics, Inc, Brian Lenz, Vice President and Chief Financial Officer
Avison Young, Tom Giannone, vice-chair
BDO, Matt Riviello Assurance Partner
BioNJ, John Slotman, Vice President, Government Affairs
Contravir, John Cavan, CFO
EisnerAmper, John Pennett, Partner
EY, Ardal Ural, Partner, Life Sciences
EY, Joel Wagner, Senior Manager
EY, Tony Torrington, Partner
Genmab, Anthony Pagano, SVP – Global Finance
Katten Muchin Rosenman, Jason Vigna, Partner
Katten Muchin Rosenman, Jonathan Rotenberg, Partner
Mirata Pharmaceuticals, Scott Megaffin, President & COO
Matinas Biopharma Holdings, Keith Kucinski, CFO
Ovid Therapeutics, Tim Daly, CBO & CFO